155 related articles for article (PubMed ID: 7407416)
1. Localized and indolent myeloma.
Alexanian R
Blood; 1980 Sep; 56(3):521-5. PubMed ID: 7407416
[TBL] [Abstract][Full Text] [Related]
2. Clinical classification of plasma cell myeloma.
Conklin R; Alexanian R
Arch Intern Med; 1975 Jan; 135(1):139-43. PubMed ID: 1111462
[TBL] [Abstract][Full Text] [Related]
3. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of asymptomatic multiple myeloma.
Alexanian R; Barlogie B; Dixon D
Arch Intern Med; 1988 Sep; 148(9):1963-5. PubMed ID: 2458080
[TBL] [Abstract][Full Text] [Related]
5. Cervical lymph node metastasis as the first manifestation of localized extramedullary plasmacytoma.
Fishkin BG; Spiegelberg HL
Cancer; 1976 Oct; 38(4):1641-4. PubMed ID: 991083
[TBL] [Abstract][Full Text] [Related]
6. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos LA; Maniatis A; Alexanian R
Blood; 2000 Sep; 96(6):2037-44. PubMed ID: 10979944
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
8. Smoldering, asymptomatic stage 1, and indolent myeloma.
Greipp PR
Curr Treat Options Oncol; 2000 Jun; 1(2):119-26. PubMed ID: 12057049
[TBL] [Abstract][Full Text] [Related]
9. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoma of the lung: an indolent disease resistant to conventional myeloma treatment: report of a case.
Marisavljevic D; Markovic O; Cemerkic-Martinovic V; Ponomarev D
Med Oncol; 2005; 22(2):207-10. PubMed ID: 15965286
[TBL] [Abstract][Full Text] [Related]
11. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1063-7. PubMed ID: 9719116
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoma. Treatment results and conversion to myeloma.
Holland J; Trenkner DA; Wasserman TH; Fineberg B
Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
14. An indolent course of multiple myeloma mimicking a solitary thyroid cartilage plasmacytoma.
Aslan I; Yenice H; Baserer N
Eur Arch Otorhinolaryngol; 2002 Feb; 259(2):84-6. PubMed ID: 11954938
[TBL] [Abstract][Full Text] [Related]
15. [Refractory multiple myeloma preceded by extramedullary plasmacytoma of lymph node--a case report and review of the literature].
Ise M; Nakaseko C; Sakai C; Takagi T
Rinsho Ketsueki; 1999 Jun; 40(6):505-10. PubMed ID: 10422289
[TBL] [Abstract][Full Text] [Related]
16. [Multiple myeloma].
Pascali E; Pezzoli A; Feruglio FS
Recenti Prog Med; 1985 Apr; 76(4):225-40. PubMed ID: 3898254
[No Abstract] [Full Text] [Related]
17. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
18. Myeloma protein kinetics following chemotherapy.
McLaughlin P; Alexanian R
Blood; 1982 Oct; 60(4):851-5. PubMed ID: 7115956
[TBL] [Abstract][Full Text] [Related]
19. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?
Erturk K; Tastekin D; Gundogdu G; Tas F; Vatansever S
Biomed Pharmacother; 2016 Feb; 77():27-9. PubMed ID: 26796261
[TBL] [Abstract][Full Text] [Related]
20. Use of bone marrow particle sections in the diagnosis of multiple myeloma.
Canale DD; Collins RD
Am J Clin Pathol; 1974 Mar; 61(3):382-92. PubMed ID: 4592206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
